Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials.
Citations
4,303 citations
2,529 citations
2,414 citations
664 citations
663 citations
References
33,234 citations
22,227 citations
14,583 citations
5,266 citations
"Benzodiazepine versus nonbenzodiaze..." refers background in this paper
...On average, patients were older (mean age = 59 yr), severely ill (average Acute Physiology and Chronic Health Evaluation II score = 21), and mostly (75%) medical (28)....
[...]
...Characteristics of Randomized Studies Evaluating the Effect of Benzodiazepine Versus Nonbenzodiazepine-Based Sedation on Clinical Outcomes Trial (n) Trial Design Patient Population (Severity of Illness) Interventiona Method and Frequency of Sedation Assessment/Sedation Goal Daily Sedation Interruption Ventilator Weaning Protocol Used Daily Delirium Assessment Defined Outcome Data Available Carson et al (2) (132) Randomized open-label, multicenter Medical (22)b Lorazepam by intermittent bolus Ramsay every 2 hr Yes Yes No ICU LOS, ventilator days, hospital mortality Propofol Ramsay of 2–3 Jakob et al (27) (500)c Randomized double-blind, double-dummy multinational, multicenter Mixedd (45)e Midazolam RASS every 2 hr Yes Not stated Nof ICU LOS, ventilator days, 45-d mortality Dexmedetomidine RASS of 0 to –3 Pandharipande et al (4) (103) Randomized, double-blind, multicenter Mixedd (28)b Lorazepam RASS (frequency not stated) No No Yes with CAM-ICU ICU LOS, ventilator days, 28-d mortality, delirium Dexmedetomidine RASS target determined by team Riker et al (5) (366) Randomized, double-blind, multicenter Mixedd (19)b Midazolam RASS every 4 hr Yes Not stated Yes with CAM-ICU ICU LOS, ventilator days, delirium, 30-d mortality Dexmedetomidine RASS of –2 to +1 Ruokonen et al (6) (67) Randomized, double-blind, double-dummy, multicenter Mixedd (2.5)g Midazolam RASS (frequency not stated) Yes Not stated Yes, but no details provided ICU LOS Dexmedetomidine RASS target determined by team Weinbroum et al (3) (67) Randomized, unblinded Mixedd (17)b Midazolam Propofol Unique scoring system developed for study (frequency of assessment not provided) No No No ICU LOS Target light sedation LOS = length of stay, RASS = Richmond Agitation-Sedation Scale, CAM-ICU = Confusion Assessment Method for the ICU. aContinuous IV infusion unless otherwise stated. bAverage Acute Physiology and Chronic Health Evaluation II score across all study groups. cBased on intention to treat. dMixed = mixed medical/surgical population. eAverage Simplified Acute Physiology Score-2 across all study groups. fDelirium assessment with CAM-ICU 48 hr after sedation discontinuance. gMean organ failure....
[...]
...Trial (n) Trial Design Patient Population (Severity of Illness) Interventiona Method and Frequency of Sedation Assessment/Sedation Goal Daily Sedation Interruption Ventilator Weaning Protocol Used Daily Delirium Assessment Defined Outcome Data Available Carson et al (2) (132) Randomized open-label, multicenter Medical (22)b Lorazepam by intermittent bolus Ramsay every 2 hr Yes Yes No ICU LOS, ventilator days, hospital mortality Propofol Ramsay of 2–3 Jakob et al (27) (500)c Randomized double-blind, double-dummy multinational, multicenter Mixedd (45)e Midazolam RASS every 2 hr Yes Not stated Nof ICU LOS, ventilator days, 45-d mortality Dexmedetomidine RASS of 0 to –3 Pandharipande et al (4) (103) Randomized, double-blind, multicenter Mixedd (28)b Lorazepam RASS (frequency not stated) No No Yes with CAM-ICU ICU LOS, ventilator days, 28-d mortality, delirium Dexmedetomidine RASS target determined by team Riker et al (5) (366) Randomized, double-blind, multicenter Mixedd (19)b Midazolam RASS every 4 hr Yes Not stated Yes with CAM-ICU ICU LOS, ventilator days, delirium, 30-d mortality Dexmedetomidine RASS of –2 to +1 Ruokonen et al (6) (67) Randomized, double-blind, double-dummy, multicenter Mixedd (2.5)g Midazolam RASS (frequency not stated) Yes Not stated Yes, but no details provided ICU LOS Dexmedetomidine RASS target determined by team Weinbroum et al (3) (67) Randomized, unblinded Mixedd (17)b Midazolam Propofol Unique scoring system developed for study (frequency of assessment not provided) No No No ICU LOS Target light sedation LOS = length of stay, RASS = Richmond Agitation-Sedation Scale, CAM-ICU = Confusion Assessment Method for the ICU. aContinuous IV infusion unless otherwise stated. bAverage Acute Physiology and Chronic Health Evaluation II score across all study groups. cBased on intention to treat. dMixed = mixed medical/surgical population. eAverage Simplified Acute Physiology Score-2 across all study groups. fDelirium assessment with CAM-ICU 48 hr after sedation discontinuance. gMean organ failure....
[...]
...Pandharipande et al (4) (103) Randomized, double-blind, multicenter Mixedd (28)b Lorazepam RASS (frequency not stated) No No Yes with CAM-ICU ICU LOS, ventilator days, 28-d mortality, delirium Dexmedetomidine RASS target determined by team...
[...]
3,005 citations